Doctor Robert E. Pluenneke, MD is an expert in the field of Hematology. He went to University of Kansas School of Medicine. Robert Pluenneke is a published doctor. He published 3 publications, including: 'Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer.' He accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1205808672 | |
NPPES Provider LastName | PLUENNEKE | |
NPPES Provider FirstName | ROBERT | |
NPPES Provider ZIPCode | 641541493 | |
NPPES Provider State | MO | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1952.0 | |
Distinct Opioid Count | 10.0 | |
Opioid Claim Count | 384.0 | |
Percent Opioid Claims | 19.67 |
National Provider Identifier [NPI] | 1205808672 |
Last Name Of The Provider | PLUENNEKE |
First Name Of The Provider | ROBERT |
View All |
Dr. Hamid M. Zia, MD
This Doctor is OpenDoctor Recommended. |
|
Mary Kellam, NP
This Doctor is OpenDoctor Recommended. |
|
Dr. Lee Lopata, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Jamie P. Rigden, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Ace Allen, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Kelly B. Pendergrass, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Jill A. Moormeier, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Mark T. Stivers, MD | |
Dr. Ali Shwaiki, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. John W. Goodwin, MD | |
Dr. Chester W. Stone, MD |